Acquisition Opportunity Atlantic Research Group has been acquired by Evestia Clinical, forming a larger mid-tier CRO with global reach. This presents a sales opportunity to align trial development services with the expanded capabilities and integrated offerings of the combined entity.

Global Expansion ARG has grown internationally with an office in Munich and a global service footprint. Target potential clients seeking European or cross‑border trial support could benefit from ARG’s, now broader, global CRO capabilities and local EU access.

Therapeutic Expertise ARG specializes in oncology, immunology, and neurology with a track record of over 50 market authorizations. A sales focus can target sponsors in these therapeutic areas requiring full-service clinical program development and advanced analytics.

Technology Stack The organization emphasizes first‑in‑class technology platforms and data analytics, including Smartsheet and Piwik PRO Core. This can be leveraged to position ARG as a data‑driven partner for endpoints, trial optimization, and digital trial execution.

Strategic Partnerships Recent collaborations and high-level hires (VP Scientific Affairs in Oncology, CFO appointment) indicate a growth‑oriented, relationship‑driven organization. This suggests opportunities to pursue strategic alliances, co‑development studies, or expanded consulting services.